SCHEMBL9679244

SCHEMBL9679244

CC(NCC(c1ccccc1)c1ccccc1)C(=O)Nc1c(C(C)C)cccc1C(C)C

nearest known ligand 0.58

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.52
LMNA P02545 1/20 0.52
MEN1 O00255 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8321568 0.80
SCHEMBL9678830 0.80 KMT2A (0.55) KMT2ALMNAMEN1
SCHEMBL9678841 0.80 KMT2A (0.55) KMT2ALMNAMEN1
SCHEMBL9679372 0.78 KMT2A (0.77) KMT2ALMNAMEN1
SCHEMBL9843989 0.78 KMT2A (0.58) KMT2ALMNAMEN1
SCHEMBL5799250 0.77 KMT2A (0.58) KMT2ALMNAMEN1
SCHEMBL9679740 0.77 KMT2A (0.58) KMT2ALMNAMEN1
SCHEMBL9679362 0.76 KMT2A (0.63) KMT2ALMNAMEN1
SCHEMBL9678908 0.76 KMT2A (0.51) KMT2ALMNAMEN1
SCHEMBL9119155 0.75 APAF1 (0.56) KMT2ALMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP claimed
US-5153226-A Administering as anticholesterol agents, for atherosclerosis WARNER-LAMBERT COMPANY (US) 1992-10-06 US disclosed
EP-0415413-A1 Acat inhibitors WARNER-LAMBERT COMPANY (US) 1991-03-06 EP disclosed